Radiogenetic therapy: Strategies to overcome tumor resistance

Current Pharmaceutical Design

Volumn 9, Issue 26, 2003, Pages 2105-2112

  Marples, B ^a   Greco, O ^a   Joiner, M C ^a   Scott, S D ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

CArG elements; GDEPT; Gene therapy; HRE; Hypoxia; Radiation

Indexed keywords

1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; ADENOVIRUS VECTOR; COMPLEMENTARY DNA; ESCHERICHIA COLI PROTEIN; FLUCYTOSINE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; LIPOSOME; MITOMYCIN C; NAKED DNA; OXYGEN; PHOSPHOGLYCERATE KINASE; PORFIROMYCIN; PRODRUG; PROTEIN BAX; PROTEIN C FOS; PROTEIN TYROSINE KINASE; SUPEROXIDE DISMUTASE; THYMIDINE KINASE; TIRAPAZAMINE; TRANSCRIPTION FACTOR EGR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANAEROBIC BACTERIUM; CANCER RADIOTHERAPY; CYTOTOXICITY; DRUG ACTIVATION; DRUG SELECTIVITY; DRUG TARGETING; ESOPHAGUS STRICTURE; GENE EXPRESSION REGULATION; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIVITY; REVIEW; SOLID TUMOR; SUICIDE GENE; SUICIDE GENE THERAPY; TUMOR RESISTANCE; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; NEOPLASMS; PROMOTER REGIONS (GENETICS); RADIOTHERAPY, ADJUVANT;

EID: 0141538139     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033454090     Document Type: Review

References (125)

1. Brown JM. Int J Radiat Oncol Biol Phys 2001; 49: 319-26.
2. Harrington KJ, Melcher AA, Bateman AR, Ahmed A, Vile RG. Clin Oncol (R Coll Radiol) 2002; 14: 148-69.
3. Harrington KJ, Bateman AR, Melcher AA, Ahmed A, Vile RG. Clin Oncol (R Coll Radiol) 2002; 14: 3-16.
4. Human Gene Marker/Therapy Clinical Protocols. Hum Gene Ther 2000; 11: 2543-617.
5. Greco O, Scott SD, Marples B, Dachs GU. Front Biosci 2002; 7: d1516-24.
6. Boothman DA, Bouvard I, Hughes EN. Cancer Res 1989; 49; 2871-2878.
7. Fornace AJ. Annu Rev Genet 1992; 26: 507-526.
8. Boothman DA, Majmudar G, Johnson T. Radiation Research 1994; 0138.
9. Amundson SA, Do KT, Fornace AJ. Jr Radiat Res 1999; 152: 225-231.
10. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. Cell 1993; 75: 817-25.
11. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, et al. Cell 1992; 71: 587-97.
12. Zhan Q, Lord KA, Alamo IJ, Hollander MC, Carrier F, Ron D, et al. J Mol Cell Biol 1994; 14: 2361-2371.
13. Seung LP, Mauceri HJ, Beckett MA, Hallahan DE, Hellman S, Weichselbaum RR. Cancer Res 1995; 55: 5561-5.
14. Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, et al. Gene Ther 1996; 3: 1042-68.
15. Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR. Gene Ther 1998; 5: 293-300.
16. Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR, et al. Proc Natl Acad Sci USA 1992; 89: 10149-53.
17. Datta R, Taneja N, Sukhatme VP, Qureshi SA, Weichselbaum R, Kufe DW. Proc Natl Acad Sci USA 1993; 90: 2419-2422.
18. Christy B, Nathans D. Mol Cell Biol 1989; 9: 4889-95.
19. Treisman R. Semin Cancer Biol 1990; 1: 47-58.
20. Shaw PE, Schroter H, Nordheim A. Cell 1989; 56: 563-72.
21. Dalton S, Treisman R. Cell 1992; 68: 597-612.
22. Hill CS, Marais R, John S, Wynne J, Dalton S, Treisman R. Cell 1993; 73: 395-406.
23. Tsai-Morris CH, Cao XM, Sukhatme VP. Nucleic Acids Res 1988; 16: 8835-46.
24. Sakamoto KM, Bardeleben C, Yates KE, Raines MA, Golde DW, Gasson JC. Oncogene 1991; 6: 867-71.
25. Christy B, Nathans D. Proc Natl Acad Sci USA 1989; 86: 8737-41.
26. Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme VP, et al. Cancer Res 1994; 54: 4266-9.
27. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, et al. Nat Med 1995; 1: 786-91.
28. Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR. Cancer Res 1996; 56: 4311-4.
29. Mauceri HJ, Seung LP, Grdina WL, Swedberg KA, Weichselbaum RR. Radiat Oncol Investig 1997; 5: 220-6.
30. Joki T, Nakamura M, Ohno, T. Hum Gene Ther 1995; 6: 1507-13.
31. Takahashi T, Namiki Y, Ohno T. Hum Gene Ther 1997; 8: 827- 833.
32. Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, et al. Hum Gene Ther 1999; 10: 1509-19.
33. Marples B, Scott SD, Hendry JH, Embleton MJ, Lashford LS, Margison GP. Gene Ther 2000; 7: 511-517.
34. Scott SD, Joiner MC, Marples B. Gene Ther 2002; 9: 1396-1402.
35. Kim JH, Kim SH, Brown SL, Freytag SO. Cancer Res 1994; 54: 6053-6.
36. Kim JH, Kim SH, Kolozsvary A, Brown SL, Kim OB, Freytag SO. Int J Radiat Oncol Biol Phys 1995; 33: 861-8.
37. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, et al. Cancer Res 1993; 53: 5274-83.
38. Elliott G, O'Hare P. Cell 1997; 88: 223-33.
39. Lai Z, Han I, Zirzow G, Brady RO, Reiser J. Proc Natl Acad Sci USA 2000; 97: 11297-302.
40. Wybranietz WA, Gross CD, Phelan A, O'Hare P, Spiegel M, Graepler F, et al. Gene Ther 2001; 8: 1654-64.
41. Zender L, Kock R, Eckhard M, Frericks B, Gosling T, Gebhardt T, et al. Gastroenterology 2002; 123: 608-18.
42. Marples B, Greco O, Joiner MC, Scott SD. Eur J Cancer 2002; 38: 231-9.
43. Luft FC. J Mol Med 1999; 77: 575-6.
44. Derer W, Easwaran HP, Knopf CW, Leonhardt H, Cardoso MC. J Mol Med 1999; 77, 609-13.
45. Lai Z, Brady RO. J Neurosci Res 2002; 67: 363-71.
46. Wills KN, Atencio IA, Avanzini JB, Neuteboom S, Phelan A, Philopena J, et al. J Virol 2001; 75: 8733-41.
47. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, et al. Hum Gene Ther 2002; 13: 553-68.
48. Rogulski KR, Wing MS, Paielli DL, Gilbert JD, Kim JH, Freytag SO. Hum Gene Ther 2000; 11: 67-76.
49. Press OW, Rasey J. Semin Oncol 2000; 27: 62-73.
50. Mairs RJ, Cunningham SH, Boyd M, Carlin S. Curr Pharm Des 2000; 6: 1419-32.
51. Mairs RJ. Eur J Cancer 1999; 35: 1171-3.
52. Boyd M, Mairs RJ, Cunningham SH, Mairs SC, McCluskey A, Livingstone A, et al. J Gene Med 2001; 3: 165-72.
53. Boyd M, Mairs RJ, Mairs SC, Wilson L, Livingstone A, Cunningham SH, et al. Oncogene 2001; 20: 7804-8.
54. Boyd M, Cunningham SH, Brown MM, Mairs RJ, Wheldon TE. Gene Ther 1999; 6: 1147-52.
55. Cunningham S, Boyd M, Brown MM, Carlin S, McCluskey A, Livingstone A, et al. Med Pediatr Oncol 2000; 35: 708-11.
56. Carlin S, Cunning SH, Boyd M, McCluskey AG, Mairs RJ. Cancer Gene Ther 2000; 7: 1529-1536.
57. Epperly MW, Gretton JA, DeFilippi SJ, Greenberger JS, Sikora CA, Liggitt D, et al. Radiat Res 2001; 155: 2-14.
58. Epperly MW, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger JS. Gene Ther 2000; 7: 1011-8.
59. Nordsmark M, Overgaard M, Overgaard J. Radiother Oncol 1996; 41: 31-9.
60. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Radiother Oncol 1999; 53: 113-7.
61. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al. Radiother Oncol 1998; 48: 149-56.
62. Knocke TH, Weitmann HD, Feldmann HJ, Selzer F, Potter R. Radiother Oncol 1999; 53: 99-104.
63. Nordsmark M, Overgaard J. Radiother Oncol 2000; 57: 39-43.
64. Hockel M, Schlenger K, Hockel S, Vaupel P. Cancer Res 1999; 59: 4525-8.
65. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al. J Nature 1996; 379: 88-91.
66. Sundfor K, Lyng H, Rofstad EK. Br J Cancer 1998; 78: 822-7.
67. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia A. J Cancer Res 1996; 56: 4315-9.
68. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, et al. Nat Med 1997; 3: 515-520.
69. Brown JM, Giaccia A. J Cancer Res 1998; 58: 1408-16.
70. Greco O, Dachs GU. J Cell Physiol 2001; 187: 22-36.
71. Dachs GU, Tozer GM. Eur J Cancer 2000; 36: 1649-60.
72. Wang GL, Jiang BH, Rue EA, Semenza GL. Proc Natl Acad Sci USA 1995; 92: 5510-4.
73. Gastpar H. Curr Med Res Opin 1981; 7: 142-55.
74. Wang GL, Semenza GL. Proc Natl Acad Sci USA 1993; 90: 4304-8.
75. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. J Biol Chem 1997; 272: 11205-14.
76. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. J Nature 1999; 399: 271-5.
77. Huang LE, Gu J, Schau M, Bunn HF. Proc Natl Acad Sci USA 1998; 95: 7987-92.
78. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. J Biol Chem 1999; 274: 6519-25.
79. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Science 2001; 292: 468-72.
80. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, et al. Proc Natl Acad Sci USA 1996; 93: 12969-73.
81. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, Poellinger L. Mol Cell Biol 2000; 20: 402-15.
82. Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM. Nat Med 2000; 6: 1335-40.
83. Koshikawa N, Takenaga K, Tagawa M, Sakiyama S. Cancer Res 2000; 60: 2936-41.
84. Kaliberov SA, Buchsbaum DJ, Gillespie GY, Curiel DT, Arafat WO, Carpenter M, et al. A Mol Ther 2002; 6: 190-8.
85. Hanahan D, Weinberg RA. Cell 2000; 100: 57-70.
86. Shibata T, Giaccia AJ, Brown JM. Neoplasia 2002; 4: 40-8.
87. Stratford IJ, Workman P. Anticancer Drug Des 1998; 13: 519-28.
88. Saunders MP, Patterson AV, Chinje EC, Harris AL, Stratford IJ. Br J Cancer 2000; 82: 651-6.
89. Patterson AV, Saunders MP, Chinje EC, Talbot DC, Harris AL, Strafford IJ. Br J Cancer 1997; 76: 1338-47.
90. Patterson AV, Williams KJ, Cowen RL, Jaffar M, Telfer BA, Saunders M, et al. Gene Ther 2002; 9: 946-54.
91. Ebert BL, Firth JD, Ratcliffe PJ. J Biol Chem 1995; 270: 29083-9.
92. Muller JM, Krauss B, Kaltschmidt C, Baeuerle PA, Rupee RA. J Biol Chem 1997; 272: 23435-9.
93. Greco O, Marples B, Dachs GU, Willams KJ, Patterson AV, Scott SD. Gene Ther 2002; 9: 1403-11.
94. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, et al. Cancer Res 1999; 59: 3374-8.
95. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Proc Natl Acad Sci USA 1998; 95: 11715-20.
96. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, et al. J Biol Chem 2000; 275: 25130-8.
97. Kuroda T, Mikawa K, Mishima H, Kishimoto A. J Biochem 1991; 110: 364-368.
98. Chua CC, Hamdy RC, Chua BH. Free Radic Biol Med 1998; 25: 891-7.
99. Kosmidou I, Xagorari A, Roussos C, Papapetropoulos A. Am J Physiol Lung Cell Mol Physiol 2001; 280: L585-92.
100. Gleadle JM, Ebert BL, Ratcliffe PJ. Eur J Biochem 1995; 234: 92-9.
101. Huang LE, Arany Z, Livingston DM, Bunn HF. J Biol Chem 1996; 271: 32253-9.
102. Fandrey J, Frede S, Ehleben W, Porwol T, Acker H, Jelkmann W. Kidney Int 1997; 51: 492-6.
103. Gonzalez-Flecha B, Reides C, Cutrin JC, Llesuy SF, Boveris A. Hepatology 1993; 18: 881-9.
104. Datta R, Hallahan DE, Kharbanda SM, Rubin E, Sherman ML, Huberman F, et al. Biochemistry 1992; 31: 8300-6.
105. Bonventre JV, Sukhatme VP, Bamberger M, Ouellette AJ, Brown D. Cell Regul 1991; 2: 251-60.
106. Yan SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM, et al. J Biol Chem 1999; 274: 15030-40.
107. Lo LW, Cheng JJ, Chiu JJ, Wung BS, Liu YC, Wang DL. J Cell Physiol 2001; 188: 304-12.
108. Yan SF, Lu J, Zou YS, Kisiel W, Mackman N, Leitges M, et al. J Biol Chem 2000; 275: 11921-8.
109. Greco O, Folkes LK, Wardman P, Tozer GM, Dachs GU. Cancer Gene Ther 2000; 7: 1414-20.
110. Scott SD, Marples B. Gene Ther 2000; 7: 1706.
111. Scott SD, Marples B, Hendry JH, Lashford LS, Embleton MJ, Hunter RD, et al. Gene Ther 2000; 7: 1121-1125.
112. Lohr F, Hu K, Huang Q, Zhang L, Samulski TV, Dewhirst MW, et al. Int J Radiat Oncol Biol Phys 2000; 48: 1513-8.
113. Nettelbeck DM, Jerome V, Muller R. Trends Genet 2000; 16: 174-81.
114. Malmgren RA, Flanigan CC. Cancer Res 1955; 15: 473-478.
115. Carey RW, Holland JF, Whang HY, Neter E, Bryant B. Eur J Cancer 1967; 3: 37-46.
116. Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP, et al. Gene Ther 1996; 3: 173-8.
117. Lemmon MJ, van Zijl P, Fox ME, Mauchline ML, Giaccia AJ, Minton NP, et al. Gene Ther 1997; 4: 791-6.
118. Liu SC, Minton NP, Giaccia AJ, Brown JM. Gene Ther 2002; 9: 291-6.
119. Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi S. Cancer Gene Ther 2000; 7: 269-74.
120. Pawelek JM, Low KB, Bermudes D. Cancer Res 1997; 57: 4537-44.
121. Lambin P, Theys J, Landuyt W, Rijken P, van der Kogel AJ, Van der Schueren E, et al. Anaerobe 1998; 4: 183-188.
122. Nuyts S, Van Mellaert L, Theys J, Landuyt W, Bosmans E, Anne J, et al. Gene Ther 2001; 8: 1197-201.
123. Brandes AA, Basso U, Pasetto LM, Ermani M. New strategy developments in brain tumor therapy. Curr Pharm Des 2001; 7(16): 1553-80.
124. de Graaf M, Boven E, Scheeren HW, Haisma HJ, Pinedo HM. Beta-glucuronidase-mediated drug release. Curr Pharm Des 2002; 8(15): 1391-403.
125. McNally VA, Patterson AV, Williams KJ, Cowen RL, Stratford IJ, Jaffar M. Antiangiogenic bioreductive and gene therapy approaches to the treatment of hypoxic tumours. Curr Pharm Des 2002; 8(15): 1319-33.